Get Savvy Investor
Stock Alerts

Latest news on ‘Health & Drug’

  • Medicare back on the brink over cuts to doctors

    WASHINGTON (AP) – Politicians of both parties outdo each other vying for the approval of seniors, but their inability to compromise on the federal budget has put Medicare in the [...]

  • Health Care: Justices to Have Last Word?

    Time – (WASHINGTON) — The weight of a Supreme Court decision isn’t likely to settle the contentious debate over health care in America, a nation disdainful of big government and [...]

  • Johnson & Johnson details drug pipeline advances

    TRENTON, N.J. (AP) — Johnson & Johnson said Thursday that its growing pharmaceutical business is in a very strong position compared to competitors, with plans to seek approval of 11 [...]

  • Sanofi, Genzyme Boards Said Near to Approving Takeover at About $74-Share

    Bloomberg – Sanofi-Aventis SA and Genzyme Corp. are likely to approve a takeover of the U.S. biotechnology company today and are discussing a price of about $74 a share plus [...]

  • Glaxo Takes $3.4 Billion Charge on Legal Problems

    The British drug maker, GlaxoSmithKline, announced Monday that it was setting aside $3.4 billion to pay for United States government investigations and for product liability cases over its marketing of [...]

  • Merck falls on drug study woes

    MarketWatch — Shares of pharmaceutical giant Merck & Co. fell more than 6% Thursday on news that the company is discontinuing a key clinical trial and modifying a second for [...]

  • J.&J. Unit Issues Recall of Rolaids

    NY Times – A unit of Johnson & Johnson announced a nationwide recall on Thursday of all lots — more than 13 million packages — of the soft chewable versions [...]

  • J&J confirms widely expanded contact lens recall

    NEW YORK (Reuters) – Johnson & Johnson, which has been beset by product recalls, on Wednesday confirmed that it recalled nearly five times as many contact lenses as the 100,000 [...]

  • U.S. Debt Proposal Would Cut Social Security, Taxes, Medicare

    Bloomberg – A presidential commission’s leaders proposed a $3.8 trillion deficit-cutting plan that would cut Social Security and Medicare, reduce income-tax rates and eliminate tax breaks including the mortgage-interest deduction.
    The [...]

  • P&G Earnings Fall 6.8% Due to Higher Costs

    By ANJALI CORDEIRO
    Procter & Gamble Co.’s fiscal first-quarter earnings dropped 6.8% as higher commodity costs hurt margins, although sales of such key brands as Pantene and Olay climbed globally.
    The decline [...]

Disclaimer:
This site includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. savvyinvestor.com and its information providers do not guarantee the accuracy, completeness or timeliness of, or otherwise endorse, these views, opinions or recommendations, give investment advice, or advocate the purchase or sale of any security or investment or any particular investment trading strategy.